Incidence and risk factors of anthracycline-induced cardiotoxicity in long-term survivors of pediatric cancer: A population based cohort study-Reference-Cited by-同舟云学术

Incidence and risk factors of anthracycline-induced cardiotoxicity in long-term survivors of pediatric cancer: A population based cohort study

Published:2022-12 Issue:4 Volume:7 Page:136-141
ISSN:2468-1245
Container-title:Pediatric Hematology Oncology Journal
language:en
Short-container-title:Pediatric Hematology Oncology Journal

Author:

Nathan Prathana,Kulkarni Ketan,MacDonald Tamara

Publisher

Elsevier BV

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference22 articles.

1. Cardiac outcomes in survivors of pediatric and adult cancers;Nathan;Can J Cardiol,2016

2. Cardiotoxicity of anthracycline agents for the treatment of cancer : systematic review and meta-analysis of randomised controlled trials;Smith;BMC Cancer,2010

3. Dexrazoxane significantly reduces anthracycline-induced cardiotoxicity in pediatric solid tumor patients: a systematic review;Liesse;J Pediatr Hematol Oncol,2018

4. Cardiovascular disease in survivors of childhood cancer : insights into epidemiology , pathophysiology, and prevention;Armenian;J Clin Orthod,2018

5. Chemotherapy-induced cardiotoxicity in children;Bansal;Expet Opin Drug Metabol Toxicol,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Perspectives on Cardiovascular Toxicity Associated with Colorectal Cancer Drug Therapy;Pharmaceuticals;2023-10-11

2. Anthracyclines-Induced Cardiac Dysfunction: What Every Clinician Should Know;Reviews in Cardiovascular Medicine;2023-05-18

3. Natural strategies of preventing anthracycline-induced cardiotoxicity – a review;Studia Universitatis Babeş-Bolyai Biologia;2022-12-22